Skip to main content

D. E. Shaw & Co., Inc.

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1009207 New York, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,224,125
+$9,172,993 QoQ
Shares Held
542,539
+21.7% QoQ
Ownership
2.90%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 156 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. RIGL ranks #46 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,224,125 542,539
2026-03-31 $12,051,132 445,678
2025-12-31 $18,173,454 424,316
2025-09-30 $8,682,833 306,489
2022-12-31 $5,029,348 3,352,899
2022-09-30 $5,482,827 4,646,464
2022-06-30 $3,926,225 3,474,536
2022-03-31 $1,595,860 533,733
2021-12-31 $218,060 82,287
2021-09-30 $468,081 128,948
2020-12-31 $163,345 46,670
2020-09-30 $335,186 139,661
2020-06-30 $1,847,225 1,009,413
2020-03-31 $630,485 404,158